Northwestern University Feinberg School of Medicine
Skip to main content

Translational Research in Malignancy Members

The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.

Ma, Shuo

Ma, Shuo

Professor

Bio

Dr. Ma directs the clinical and translational research initiatives in chronic lymphocytic leukemia (CLL) to develop and study novel treatment agents for the treatment of CLL. Her translation... [more]

Magill, Stephen

Magill, Stephen

Assistant Professor

Bio

I am a neurosurgeon and physician-scientist focused on providing skilled and compassionate care for brain tumor patients, leading research that will advance our understanding of brain tumor biology, a... [more]

Mahalingam, Devalingam

Bio

I dedicate 75% of my time to clinical research in early drug development with a focus in gastrointestinal (GI) malignancies. Through my participation in these early clinical studies, I ... [more]

Marcus, Jenna

Marcus, Jenna

Assistant Professor

Bio

Dr. Marcus is a gynecologic oncologist interested in the surgical and medical management of gynecologic malignancies. Her research is focused on detection and management of pre-invasive disease, cance... [more]

Matei, Daniela

Bio

In the laboratory, specific interests have been investigating tumor-stroma interactions which regulate ovarian cancer metastasis, characterizing and targeting ovarian cancer stem cells, studying growt... [more]

Meeks, Joshua

Meeks, Joshua

Associate Professor

Bio

My research laboratory is focused on the molecular pathways involved in the progression of urothelial carcinoma (bladder cancer). My research has two themes: 1) to investigate the ... [more]

Mehta, Jayesh

Bio

Myeloma, Transplantation

Mirkin, Chad

Mirkin, Chad

Professor

Bio

Prof. Mirkin has pioneered the use of nanoparticle-biomolecule conjugates as synthons in materials science and the development of many nanoparticle-based extra- and intracellular biodiagnostic and the... [more]

Miska, Jason

Miska, Jason

Assistant Professor

Bio

The goal of Dr. Miska's research is to determine how the metabolism of immune cells within glioblastoma contributes to immune suppression and tumor recurrence. Furthermore, the long-term goal of ... [more]

Mittal, Bharat B.

Bio

Research interests include use of innovative treatment modalities for head and neck cancer in order to obtain better tumor control and decrease toxicity of treatment.